BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 18156968)

  • 1. Defining an appropriate threshold for the diagnosis of serous borderline tumor of the ovary: when is a full staging procedure unnecessary?
    Allison KH; Swisher EM; Kerkering KM; Garcia RL
    Int J Gynecol Pathol; 2008 Jan; 27(1):10-7. PubMed ID: 18156968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.
    McKenney JK; Balzer BL; Longacre TA
    Am J Surg Pathol; 2006 Oct; 30(10):1209-21. PubMed ID: 17001150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical factors and biomarkers in ovarian tumors development.
    Vrabie CD; Petrescu A; Waller M; Dina I
    Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of the micropapillary pattern in patients with serous borderline ovarian tumors.
    Chang SJ; Ryu HS; Chang KH; Yoo SC; Yoon JH
    Acta Obstet Gynecol Scand; 2008; 87(4):476-81. PubMed ID: 18382877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro fertilization following conservative management of stage 3 serous borderline tumor of the ovary.
    Hoffman JS; Laird L; Benadiva C; Dreiss R
    Gynecol Oncol; 1999 Sep; 74(3):515-8. PubMed ID: 10479523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are borderline tumors of the ovary safely treated by laparoscopy?
    Maneo A; Vignali M; Chiari S; Colombo A; Mangioni C; Landoni F
    Gynecol Oncol; 2004 Aug; 94(2):387-92. PubMed ID: 15297177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microinvasion links ovarian serous borderline tumor and grade 1 invasive carcinoma.
    Hogg R; Scurry J; Kim SN; Friedlander M; Hacker N
    Gynecol Oncol; 2007 Jul; 106(1):44-51. PubMed ID: 17467045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results after conservative treatment of serous borderline tumors of the ovary with a micropapillary pattern.
    Laurent I; Uzan C; Gouy S; Pautier P; Duvillard P; Morice P
    Ann Surg Oncol; 2008 Dec; 15(12):3561-6. PubMed ID: 18820973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic alterations of serous borderline tumors of the ovary compared to stage I serous ovarian carcinomas.
    Osterberg L; Akeson M; Levan K; Partheen K; Zetterqvist BM; Brännström M; Horvath G
    Cancer Genet Cytogenet; 2006 Jun; 167(2):103-8. PubMed ID: 16737908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic difficulties in serous "borderline" tumors of the ovary].
    Vereczkey I; Tóth E; Orosz Z
    Magy Onkol; 2009 Mar; 53(1):23-31. PubMed ID: 19318323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ovarian serous tumors of limited malignancy and invasive peritoneal implants. Review of the literature].
    Fondrinier E; Seince N; Verriele V; Lorimier G; Gamelin E
    Contracept Fertil Sex; 1999 Nov; 27(11):780-4. PubMed ID: 10609410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful pregnancy after conservative surgery for stage IC ovarian cancer with serous borderline tumor on controlateral ovary: a case report.
    Battaglia F; Plotti F; Zullo MA; Panici PB; Plotti G
    Gynecol Oncol; 2006 Mar; 100(3):612-4. PubMed ID: 16249017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hobnail-like cells in serous borderline tumor do not represent concomitant incipient clear cell neoplasms.
    Ohishi Y; Oda Y; Kurihara S; Kaku T; Yasunaga M; Nishimura I; Okuma E; Kobayashi H; Wake N; Tsuneyoshi M
    Hum Pathol; 2009 Aug; 40(8):1168-75. PubMed ID: 19368953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results after conservative treatment of serous borderline tumours of the ovary with stromal microinvasion but without micropapillary pattern.
    Laurent I; Uzan C; Gouy S; Pautier P; Duvillard P; Morice P
    BJOG; 2009 May; 116(6):860-2. PubMed ID: 19432576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma.
    Salvador S; Rempel A; Soslow RA; Gilks B; Huntsman D; Miller D
    Gynecol Oncol; 2008 Sep; 110(3):408-17. PubMed ID: 18597838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of ovarian cancer patients who underwent incomplete surgical staging.
    Panprom P; Lertkhachonsuk R
    J Med Assoc Thai; 2008 Sep; 91(9):1323-30. PubMed ID: 18843859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI appearances of borderline ovarian tumours.
    Bent CL; Sahdev A; Rockall AG; Singh N; Sohaib SA; Reznek RH
    Clin Radiol; 2009 Apr; 64(4):430-8. PubMed ID: 19264189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relapse and survival in early-stage ovarian cancer.
    Lenhard SM; Bufe A; Kümper C; Stieber P; Mayr D; Hertlein L; Kirschenhofer A; Friese K; Burges A
    Arch Gynecol Obstet; 2009 Jul; 280(1):71-7. PubMed ID: 19093129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinicopathologic multivariate analysis affecting recurrence of borderline ovarian tumors.
    Ren J; Peng Z; Yang K
    Gynecol Oncol; 2008 Aug; 110(2):162-7. PubMed ID: 18495223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Borderline ovarian tumors: an update].
    Tulpin L; Rouzier R; Morel O; Malartic C; Daraï E; Barranger E
    Gynecol Obstet Fertil; 2008 Apr; 36(4):422-9. PubMed ID: 18356093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.